Vanguard Group Inc ownership in GILD / Gilead Sciences, Inc.

Gilead Sciences, Inc.

CH ˙ SWX ˙ US3755581036

Security	CH:GILD / Gilead Sciences, Inc.
Institution	Vanguard Group Inc
Latest Disclosed Ownership	111,820,711 shares
Ownership	8.97%

2024-02-13 - Vanguard Group Inc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 111,820,711 shares of Gilead Sciences, Inc. (CH:GILD). This represents 8.97 percent ownership of the company. In their previous filing dated 2023-02-09 , Vanguard Group Inc had reported owning 112,038,324 shares, indicating a decrease of -0.19 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2024-02-13	2024-02-13	13G/A	112,038,324	111,820,711	-0.19	8.97	0.45
2023-02-09	2023-02-09	13G/A	105,803,799	112,038,324	5.89	8.93	5.93
2022-02-10	2022-02-10	13G/A	102,787,017	105,803,799	2.93	8.43	2.80
2021-02-10	2021-02-10	13G/A	103,771,848	102,787,017	-0.95	8.20	0.00
2020-02-12	2020-02-12	13G/A	100,414,250	103,771,848	3.34	8.20	5.67
2019-02-11	2019-02-11	13G/A	94,765,559	100,414,250	5.96	7.76	7.03
2018-02-09	2018-02-09	13G/A	84,495,902	94,765,559	12.15	7.25	13.10
2017-02-13	2017-02-13	13G/A	85,547,536	84,495,902	-1.23	6.41	8.09
2016-02-10	2016-02-10	13G/A		85,547,536		5.93
2015-02-10	2015-02-10	13G		81,566,622		5.40

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-01-29	2025-12-31	13F	GILEAD SCIENCES	COM	375558103	121,097,336	2,113,692	1.78	14,863,487	12.54	0.2155
2025-11-07	2025-09-30	13F	GILEAD SCIENCES	COM	375558103	118,983,644	-380,582	-0.32	13,207,184	-0.20	0.1977
2025-08-11	2025-06-30	13F	GILEAD SCIENCES	COM	375558103	119,364,226	1,893,401	1.61	13,233,912	0.54	0.2142
2025-05-09	2025-03-31	13F	GILEAD SCIENCES	COM	375558103	117,470,825	1,942,433	1.68	13,162,606	23.35	0.2380
2025-02-11	2024-12-31	13F	GILEAD SCIENCES	COM	375558103	115,528,392	185,508	0.16	10,671,358	10.35	0.1859
2024-11-13	2024-09-30	13F	GILEAD SCIENCES	COM	375558103	115,342,884	81,110	0.07	9,670,347	22.28	0.1732
2024-08-13	2024-06-30	13F	GILEAD SCIENCES	COM	375558103	115,261,774	529,199	0.46	7,908,110	-5.90	0.1519
2024-05-10	2024-03-31	13F	GILEAD SCIENCES	COM	375558103	114,732,575	2,910,147	2.60	8,404,161	-7.23	0.1665
2024-03-11	2023-12-31	13F/A-1	GILEAD SCIENCES	COM	375558103	111,822,428	137,854	0.12	9,058,735	8.23	0.1979
2024-02-14	2023-12-31	13F	GILEAD SCIENCES	COM	375558103	111,822,428	137,854		9,058,735		0.1720
2023-12-18	2023-09-30	13F/A-1	GILEAD SCIENCES	COM	375558103	111,684,574	-1,684,076	-1.49	8,369,642	-4.21	0.2056
2023-11-14	2023-09-30	13F	GILEAD SCIENCES	COM	375558103	111,684,574	-1,684,076		8,369,642		0.2056
2023-08-14	2023-06-30	13F	GILEAD SCIENCES	COM	375558103	113,368,650	394,253	0.35	8,737,322	-6.79	0.2072
2023-07-14	2023-03-31	13F/A-1	GILEAD SCIENCES	COM	375558103	112,974,397	936,073	0.84	9,373,486	-2.55	0.2387
2023-05-15	2023-03-31	13F	GILEAD SCIENCES	COM	375558103	112,972,727	934,403		9,373,347		0.2387
2023-02-10	2022-12-31	13F	GILEAD SCIENCES	COM	375558103	112,038,324	-48,947	-0.04	9,618,490	39.10	0.2619
2022-11-14	2022-09-30	13F	GILEAD SCIENCES	COM	375558103	112,087,271	1,691,194	1.53	6,914,663	1.33	0.2034
2022-08-12	2022-06-30	13F	GILEAD SCIENCES	COM	375558103	110,396,077	4,787,719	4.53	6,823,581	8.68	0.1918
2022-05-13	2022-03-31	13F	GILEAD SCIENCES	COM	375558103	105,608,358	-195,441	-0.18	6,278,417	-18.28	0.1485
2022-02-14	2021-12-31	13F	GILEAD SCIENCES	COM	375558103	105,803,799	598,438	0.57	7,682,413	4.54	0.1744
2021-11-12	2021-09-30	13F	GILEAD SCIENCES	COM	375558103	105,205,361	187,419	0.18	7,348,594	1.62	0.1825
2021-08-13	2021-06-30	13F	GILEAD SCIENCES	COM	375558103	105,017,942	754,213	0.72	7,231,535	7.32	0.1800
2021-05-14	2021-03-31	13F	GILEAD SCIENCES	COM	375558103	104,263,729	1,476,712	1.44	6,738,565	12.53	0.1823
2021-02-12	2020-12-31	13F	GILEAD SCIENCES	COM	375558103	102,787,017	64,557	0.06	5,988,372	-7.74	0.1737
2020-11-16	2020-09-30	13F	GILEAD SCIENCES	COM	375558103	102,722,460	-2,090,879	-1.99	6,491,033	-19.51	0.2148
2020-08-14	2020-06-30	13F	GILEAD SCIENCES	COM	375558103	104,813,339	-2,280,076	-2.13	8,064,339	0.72	0.2860
2020-05-15	2020-03-31	13F	GILEAD SCIENCES	COM	375558103	107,093,415	3,321,567	3.20	8,006,304	18.73	0.3412
2020-02-14	2019-12-31	13F	GILEAD SCIENCES	COM	375558103	103,771,848	1,285,513	1.25	6,743,094	3.81	0.2300
2019-11-14	2019-09-30	13F	GILEAD SCIENCES	COM	375558103	102,486,335	423,886	0.42	6,495,585	-5.80	0.2409
2019-08-14	2019-06-30	13F	GILEAD SCIENCES	COM	375558103	102,062,449	715,569	0.71	6,895,339	4.66	0.2594
2019-05-15	2019-03-31	13F	GILEAD SCIENCES	COM	375558103	101,346,880	932,630	0.93	6,588,561	4.90	0.2585
2019-02-14	2018-12-31	13F	GILEAD SCIENCES	COM	375558103	100,414,250	3,246,921	3.34	6,280,911	-16.28	0.2822
2018-12-13	2018-09-30	13F/A-2	GILEAD SCIENCES	COM	375558103	97,167,329	1,071,619	1.12	7,502,290	10.21	0.2932
2018-11-23	2018-09-30	13F/A-1	GILEAD SCIENCES	COM	375558103	97,167,329	0		7,502,290		0.2932
2018-11-14	2018-09-30	13F	GILEAD SCIENCES	COM	375558103	97,167,329	1,071,619		7,502,290
2018-08-14	2018-06-30	13F	GILEAD SCIENCES	COM	375558103	96,095,710	1,016,632	1.07	6,807,420	-5.03	0.2848
2018-05-15	2018-03-31	13F	GILEAD SCIENCES	COM	375558103	95,079,078	313,519	0.33	7,168,010	5.58	0.3135
2018-02-14	2017-12-31	13F	GILEAD SCIENCES	COM	375558103	94,765,559	237,763	0.25	6,789,005	-11.35	0.2969
2017-11-14	2017-09-30	13F	GILEAD SCIENCES	COM	375558103	94,527,796	1,685,836	1.82	7,658,643	16.55	0.3580
2017-08-24	2017-06-30	13F/A-1	GILEAD SCIENCES	COM	375558103	92,841,960	2,148,697	2.37	6,571,355	6.68	0.3237
2017-08-11	2017-06-30	13F	GILEAD SCIENCES	COM	375558103	92,841,960	2,148,697		6,571,355
2017-05-12	2017-03-31	13F	GILEAD SCIENCES	COM	375558103	90,693,263	6,197,361	7.33	6,159,886	1.80	0.3167
2017-02-14	2016-12-31	13F	GILEAD SCIENCES	COM	375558103	84,495,902	1,414,626	1.70	6,050,751	-7.95	0.3375
2016-11-14	2016-09-30	13F	GILEAD SCIENCES	COM	375558103	83,081,276	676,780	0.82	6,573,390	-4.38	0.3861
2016-08-10	2016-06-30	13F	GILEAD SCIENCES	COM	375558103	82,404,496	-1,298,325	-1.55	6,874,184	-10.60	0.4269
2016-05-13	2016-03-31	13F	GILEAD SCIENCES	COM	375558103	83,702,821	-1,844,715	-2.16	7,688,941	-11.18	0.4981
2016-02-08	2015-12-31	13F	GILEAD SCIENCES	COM	375558103	85,547,536	596,921	0.70	8,656,555	3.78	0.5821
2015-11-12	2015-09-30	13F/A-1	GILEAD SCIENCES	COM	375558103	84,950,615	1,120,614	1.34	8,341,301	-15.01	0.3542
2015-11-12	2015-09-30	13F/A-1	GILEAD SCIENCES	COM	375558103	84,950,615	1,120,614		8,341,301		0.3542
2015-11-12	2015-09-30	13F	GILEAD SCIENCES	COM	375558103	95,617,481			8,685,492
2015-08-13	2015-06-30	13F	GILEAD SCIENCES	COM	375558103	83,830,001	126,641	0.15	9,814,817	19.49	0.6635
2015-05-15	2015-03-31	13F/A-1	GILEAD SCIENCES	COM	375558103	83,703,360	2,136,738	2.62	8,213,809	6.83	0.5571
2015-05-14	2015-03-31	13F	GILEAD SCIENCES	COM	375558103	83,703,360			8,213,809
2015-02-12	2014-12-31	13F	GILEAD SCIENCES	COM	375558103	81,566,622	2,285,655	2.88	7,688,470	-8.90	0.5537
2014-11-12	2014-09-30	13F	GILEAD SCIENCES	COM	375558103	79,280,967	539,896	0.69	8,439,459	29.27	0.6579
2014-08-11	2014-06-30	13F	GILEAD SCIENCES	COM	375558103	78,741,071	1,452,837	1.88	6,528,422	19.20	0.5144
2014-05-13	2014-03-31	13F	GILEAD SCIENCES	COM	375558103	77,288,234	2,440,405	3.26	5,476,645	-2.63	0.4606
2014-02-12	2013-12-31	13F	GILEAD SCIENCES	COM	375558103	74,847,829	1,360,651	1.85	5,624,796	21.80	0.4946
2013-11-07	2013-09-30	13F	GILEAD SCIENCES	COM	375558103	73,487,178	1,437,584	2.00	4,617,945	25.16	0.4510
2013-08-13	2013-06-30	13F	GILEAD SCIENCES	COM	375558103	72,049,594	72,049,594		3,689,687		0.3875

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.